WH Reviewing FDA’s Long-Awaited Rx-To-OTC Proposed Rule

By Beth Wang / March 11, 2022 at 5:51 PM
The White House is reviewing a long-awaited FDA proposed rule that would help switch more prescription drugs to over-the-counter status, which HHS and a key industry group say could help lower health care costs. FDA sent the proposal to the White House Office of Management and Budget for review Thursday (March 10). OTC industry group the Consumer Healthcare Products Association told Inside Health Policy it’s pleased FDA is moving forward on the regulation, which has been years in the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.